| Literature DB >> 27486662 |
Rajeev Kumar Verma1,2, Eugenio Abela3, Kaspar Schindler3, Heinz Krestel3, Elisabeth Springer1, Adrian Huber4, Christian Weisstanner1, Martinus Hauf1, Jan Gralla1, Roland Wiest1.
Abstract
OBJECTIVE: The aim of this study was to investigate variant patterns of cortical venous oxygenation during status epilepticus (SE) using susceptibility-weighted imaging (SWI).Entities:
Mesh:
Year: 2016 PMID: 27486662 PMCID: PMC4972361 DOI: 10.1371/journal.pone.0160495
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Detailed patient data.
Detailed information on patients including underlying seizure pathology, findings in SWI, perfusion imaging and DWI. Division of patients according to the findings in SWI and perfusion imaging: patients 1–8, group 1; patients 9–15, group 2; patients 16–23, group 3; patients 24–26, group 4.
| PatientNo. | Sex, age | Underlying seizure pathology | Cortical veins in SWI | CBF (color coded) | CBF±SD (ill- or normal perfusion appearance in color-coded maps) | CBF±SD (contralateral side with normal perfusion appearance in color-coded maps) | DWI DR | PSE/NCSE | EEG |
|---|---|---|---|---|---|---|---|---|---|
| 1 | F, 58 | Encephalitis, no cerebral swelling | none | symmetric | 93.26±22.79 | 110.78±31.65 | none | PSE | Y |
| 2 | F, 78 | non-lesional | rarified | symmetric | 73.04±4.44 | 74.15±0.40 | none | PSE | Y |
| 3 | M, 82 | non-lesional | none | symmetric | 85.66±49.38 | 62.10±46.45 | none | NCSE | Y |
| 4 | M, 19 | Encephalitis, no cerebral swelling | none | symmetric | 96.64±46.76 | 113.03±49.44 | none | PSE | N |
| 5 | F, 63 | H/o infarction left | none | symmetric | 146.59±40.05 | 151.71±35.60 | none | PSE | N |
| 6 | M, 41 | non-lesional | rarified | symmetric | 102.37±16.86 | 100.8±30.04 | none | NCSE | Y |
| 7 | F, 60 | H/o several infarctions | none | symmetric | 130.72±25.80 | 141.60±8.71 | none | PSE | N |
| 8 | F, 63 | cerebral lymphoma | none | symmetric | 93.17±27.39 | 89.17±35.77 | none | NCSE | Y |
| Mean CBF± values (group 1) | 102.68±29.18 | 105.41±29.76 | none | ||||||
| 9 | F, 60 | non-lesional | rarified | multifocally increased | 82.73±28.55 | 50.28±25.32 | none | NCSE | Y |
| 10 | F, 62 | H/o aneurysm clipping and SAH | none | multifocally increased | 138.82±16.88 | 63.26±5.24 | none | NCSE | Y |
| 11 | F, 78 | non-lesional | none | multifocally increased | 110.31±15.14 | 63.36±0.78 | focally | NCSE | Y |
| 12 | F, 84 | parenchymal gliosis | none | multifocally increased | 85.15±26.08 | 44.00±11.26 | focally | NCSE | Y |
| 13 | M, 73 | parenchymal gliosis after hemorrhage | none | multifocally increased | 166.95±45.12 | 60.70±7.61 | none | PSE | N |
| 14 | M, 57 | glioblastoma multiforme | none | multifocally increased | 108.10±29.92 | 48.96±22.21 | focally | NCSE | Y |
| 15 | M, 72 | metastasis of unknown primary tumor | rarified | multifocally increased | 139.26±32.29 | 59.29±20.95 | focally | NCSE | Y |
| Mean CBF± values (group 2) | 118.76±27.71 | 55.69±13.33 | none | ||||||
| 16 | M, 55 | parenchymal gliosis after traumatic hemorrhage | focally decreased | focally increased | 94.78±25.85 | 35.72±7.60 | Focally correlating with SWI | NCSE | Y |
| 17 | F, 22 | non-lesional | focally decreased | focally increased | 140.53±39.61 | 75.29±47.25 | focally correlating with SWI | NCSE | Y |
| 18 | F, 67 | non-lesional | focally decreased | focally increased | 96.79±30.42 | 51.29±2.94 | Focally correlating with SWI | NCSE | Y |
| 19 | F, 87 | non-lesional | focally decreased | focally increased | 87.49±23.68 | 37.20±9.57 | Focally correlating with SWI | NCSE | Y |
| 20 | M, 4 | Fever | focally decreased | focally increased | 157.64±56.49 | 41.98±2.87 | none | NCSE | Y |
| 21 | F, 73 | metastasis of bronchial carcinoma | focally decreased | focally increased | 135.02±41.16 | 51.55±14.36 | none | NCSE | Y |
| 22 | F, 6 | non-lesional | focally decreased | focally increased | 178.19±51.18 | 97.41±43.55 | none | NCSE | Y |
| 23 | F, 67 | metastasis of unknown primary tumor | focally decreased | focally increased | 96.18±24.60 | 47.78±15.82 | none | PSE | N |
| Mean CBF± values (group 3) | 123.33±36.60 | 54.78±18.00 | none | ||||||
| 24 | M, 77 | non-lesional | focally increased | focally decreased | 34.85±10.58 | 67.02±41.72 | none | PSE | N |
| 25 | F, 65 | hippocampal sclerosis | focally increased | focally decreased | 25.62±12.06 | 58.68±24.75 | none | PSE | N |
| 26 | M, 79 | non-lesional | focally increased | focally decreased | 19.81±13.17 | 40.07±14.53 | none | PSE | N |
| Mean CBF± values (group 4) | 26.76±11.94 | 55.26±27.00 | none | ||||||
CBF, cerebral blood flow; PSE, prolonged seizure episode; DR, diffusion restriction; DWI, diffusion weighted imaging; EEG, electroencephalography; H/o, history of; NCSE, non-convulsive status epilepticus; SAH, subarachnoid hemorrhage; SD, standard deviation; SWI, susceptibility weighted imaging.
Fig 1Division into subgroups according to the SWI and perfusion findings.
(A) (group 1), in SWI the cortical veins are diminished (arrows) and the rCBF pattern in color-coded maps is symmetrical and reveals no abnormality (patient No. 5: Patient had a H/o left-sided watershed infarction. During MRI acquisition patient suffered from PSE after witnessed convulsive SE before MRI). (B) (group 2) again diminished cortical veins can be seen, but the rCBF pattern shows patchy multifocal hyperperfusion (patient No. 11: Patient had a NCSE during MRI with symptoms of acute aphasia, confusion and agitation). (C) (group 3) shows focally diminished veins with corresponding focal hyperperfusion (arrows); (patient No. 23: patient suffering from PSE during MRI with global aphasia and mild hemiparesis on the right). (D) (group 4) reveals left-sided prominent cortical veins with corresponding hypoperfusion (patient No. 24: Patient suffering from PSE with severe global aphasia during MRI).
Overview of group findings.
Division of patients into groups according to the findings in SWI and perfusion imaging.
| Group | No. of patients | SWI pattern | rCBF pattern (color-coded maps) | Quantified CBF ml/100g/min (symptomatogenic) | Quantified CBF ml/100g/min (opposite) | p-value (laterality of CBF values) | Fig No. |
|---|---|---|---|---|---|---|---|
| 1 | 8/26 | Global hyperoxygenation | symmetric increase | 102.7 (SD24.2) | 105.4 (SD30.9) | 0.578 | |
| 2 | 7/26 | Global hyperoxygenation | multifocal increase | 118.8 (SD31.0) | 55.9 (SD7.8) | 0.001 | |
| 3 | 8/26 | Focal hyperoxygenation | focal increase | 123.3 (SD34.1) | 54.8 (SD21.2) | <0.001 | |
| 4 | 3/26 | Focal hypooxygenation | focal decrease | 26.8 (SD7.6) | 55.3 (SD13.8) | 0.02 |
Group 2 to 4 show significant differences in comparison of hemispheres, while in group 1 no significant difference is seen due to a global hyperperfusion in both hemispheres.
* Quantified CBF results with a statistically significant difference from the contralateral.
Fig 2Scatter plot of quantified CBF.
Each patient group is represented in an oval: group 1, blue oval; group 2, green oval; group 3, grey oval; group 4, purple oval. x-axis (CBF1): CBF value in ml/100 g/min of ill-perfused parenchyma y-axis (CBF2): CBF value in ml/100 g/min of the contralateral side. Group 1 shows a global hyperperfusion with mostly high CBF values in both hemispheres (x- and y-axis: >75 ml/100 g/min). Groups 2 and 3 show mainly unilateral higher CBF values (x-axis: >75 ml/100 g/min) and mostly normal CBF values on the opposite side (y-axis: around 50 ml/100 g/min). For group 4, CBF values are low in the ill-perfused area (x-axis: <50 ml/100 g/min), while the CBF values on the contralateral side are mostly in the normal range (y-axis: around 50 ml/100 g/min).
Fig 3SWI Serial images of a patient with PSE.
Globally diminished corticals veins due to global hyperperfusion in patients with NCSE or PSE is a new finding of this study. This is an example of a 78 y old female with NCSE (patient no. 11). Cortical veins are not visible in the minimum intensity projection SW images.